n,n-dimethylarginine has been researched along with bradykinin in 1 studies
Studies (n,n-dimethylarginine) | Trials (n,n-dimethylarginine) | Recent Studies (post-2010) (n,n-dimethylarginine) | Studies (bradykinin) | Trials (bradykinin) | Recent Studies (post-2010) (bradykinin) |
---|---|---|---|---|---|
2,216 | 228 | 1,221 | 14,195 | 355 | 1,520 |
Protein | Taxonomy | n,n-dimethylarginine (IC50) | bradykinin (IC50) |
---|---|---|---|
B2 bradykinin receptor | Homo sapiens (human) | 0.0018 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brown, NJ; Gamboa, JL; Ikizler, TA; Pretorius, M; Sprinkel, KC | 1 |
1 trial(s) available for n,n-dimethylarginine and bradykinin
Article | Year |
---|---|
Angiotensin converting enzyme inhibition increases ADMA concentration in patients on maintenance hemodialysis--a randomized cross-over study.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Arginine; Bradykinin; Cell Line; Cross-Over Studies; Double-Blind Method; Endothelium, Vascular; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Ramipril; Renal Dialysis; Valsartan | 2015 |